Data Update - Global Metformin Hydrochloride Market Insights, Forecast to 2030

• Description
• PDF Download

• Description
• PDF Download

Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.

The global key manufacturers of Metformin Hydrochloride include Keyuan Pharmaceutical, Aarti Drugs and Shijiazhuang Polee, etc, top 3 manufacturers hold a share approximately 36%. Keyuan Pharmaceutical is the world's largest Metformin Hydrochloride manufacturer, with a market share of more than 14%. India, China and Europe are the major Metformin Hydrochloride market, they have a market share of more than 68%. India is the largest market with a share of 46%. In terms of product type, Metformin HCL is the largest market segment with a share of more than 82%. In terms of applications, Metformin Hydrochloride Tablets is the largest downstream segment, with a market share of about 72%.

In terms of production side, this report researches the Metformin Hydrochloride production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Metformin Hydrochloride by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

This report presents an overview of global market for Metformin Hydrochloride, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Metformin Hydrochloride, also provides the consumption of main regions and countries.  of the upcoming market potential for Metformin Hydrochloride, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metformin Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Metformin Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Metformin Hydrochloride sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane, Keyuan Pharmaceutical, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Aarti Drugs, etc.

Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.

The global key manufacturers of Metformin Hydrochloride include Keyuan Pharmaceutical, Aarti Drugs and Shijiazhuang Polee, etc, top 3 manufacturers hold a share approximately 36%. Keyuan Pharmaceutical is the world's largest Metformin Hydrochloride manufacturer, with a market share of more than 14%. India, China and Europe are the major Metformin Hydrochloride market, they have a market share of more than 68%. India is the largest market with a share of 46%. In terms of product type, Metformin HCL is the largest market segment with a share of more than 82%. In terms of applications, Metformin Hydrochloride Tablets is the largest downstream segment, with a market share of about 72%.

In terms of production side, this report researches the Metformin Hydrochloride production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Metformin Hydrochloride by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

This report presents an overview of global market for Metformin Hydrochloride, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Metformin Hydrochloride, also provides the consumption of main regions and countries.  of the upcoming market potential for Metformin Hydrochloride, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metformin Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Metformin Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Metformin Hydrochloride sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane, Keyuan Pharmaceutical, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Aarti Drugs, etc.